Evaluate RLS-1496 Topical Cream for Actinic Keratosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Spellman, MD
Acting Chief Medical Officer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
Dow Stough, MDRecruiting - Minnesota Clinical Study Center
New Brighton, Minnesota, United States
Steven Kempers, MDRecruiting - Schlessinger Md Skin Research Center
Omaha, Nebraska, United States
Joel Schlessinger, MDRecruiting - Austin Institute for Clinical Research
Pflugerville, Texas, United States
Edward (Ted) Lain, MD, MBARecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2026
- Primary completion
- 30 Apr 2026
- Completion
- 31 May 2026
- Last update posted
- 27 Jan 2026
- Registered enrollment
- 24
- Registry id
- NCT07340697
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.